| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADORA1
|
adenosine A1 receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AKAP6
|
A kinase (PRKA) anchor protein 6
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ANK2
|
ankyrin 2, neuronal
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
AP3D1
|
adaptor-related protein complex 3, delta 1 subunit
|
|
ATG5
|
autophagy related 5
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
AVP
|
arginine vasopressin
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDKRB1
|
bradykinin receptor B1
|
|
CA2
|
carbonic anhydrase II
|
|
CA7
|
carbonic anhydrase VII
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle)
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CCK
|
cholecystokinin
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD19
|
CD19 molecule
|
|
CEMIP
|
cell migration inducing protein, hyaluronan binding
|
|
CHERP
|
calcium homeostasis endoplasmic reticulum protein
|
|
CLIC2
|
chloride intracellular channel 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
CORIN
|
corin, serine peptidase
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DMD
|
dystrophin
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EPO
|
erythropoietin
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
FCRL5
|
Fc receptor-like 5
|
|
FGF12
|
fibroblast growth factor 12
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FHL1
|
four and a half LIM domains 1
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HRC
|
histidine rich calcium binding protein
|
|
HSH2D
|
hematopoietic SH2 domain containing
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
IBTK
|
inhibitor of Bruton agammaglobulinemia tyrosine kinase
|
|
IFI6
|
interferon, alpha-inducible protein 6
|
|
IL13
|
interleukin 13
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
KNG1
|
kininogen 1
|
|
LACRT
|
lacritin
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MCOLN1
|
mucolipin 1
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NPFF
|
neuropeptide FF-amide peptide precursor
|
|
NPPB
|
natriuretic peptide B
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLN
|
phospholamban
|
|
PML
|
promyelocytic leukemia
|
|
PPP2R3C
|
protein phosphatase 2, regulatory subunit B'', gamma
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RANGRF
|
RAN guanine nucleotide release factor
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN2B
|
sodium channel, voltage gated, type II beta subunit
|
|
SCN3B
|
sodium channel, voltage gated, type III beta subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SLC25A23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23
|
|
SLC30A2
|
solute carrier family 30 (zinc transporter), member 2
|
|
SLC30A3
|
solute carrier family 30 (zinc transporter), member 3
|
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SMAD7
|
SMAD family member 7
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SPX
|
spexin hormone
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRI
|
sorcin
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TPCN2
|
two pore segment channel 2
|
|
TRDN
|
triadin
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TSPO
|
translocator protein (18kDa)
|
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
UMOD
|
uromodulin
|
|
UTS2
|
urotensin 2
|
|
UTS2R
|
urotensin 2 receptor
|
|
WNK2
|
WNK lysine deficient protein kinase 2
|
|
WNK3
|
WNK lysine deficient protein kinase 3
|
|
XCL1
|
chemokine (C motif) ligand 1
|
|
XCR1
|
chemokine (C motif) receptor 1
|